Home » Topics » Regulatory » Patents

Patents
RSS

Merck KGaA discloses new fatty acid synthase inhibitors

Feb. 19, 2015

Takeda Pharmaceutical patents new PDE2A inhibitors

Feb. 18, 2015

Novartis patent divulges PI3Kdelta/gamma inhibitors

Feb. 18, 2015

Zenith Epigenetics reports novel bromodomain inhibitors

Feb. 18, 2015

Roche develops neurogenesis-stimulating naphthyridines

Feb. 18, 2015

Nanjing Sanhome Pharmaceutical patents ABL inhibitors

Feb. 18, 2015

Polish and French team discloses 5-HT6 receptor antagonists

Feb. 17, 2015

Janssen discloses new anti-HBV compounds

Feb. 17, 2015

Actelion patents CXCR3 receptor antagonists

Feb. 17, 2015

Bayer divulges dual BRD4/PLK1 inhibitors

Feb. 17, 2015

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...